The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dietz Thomas John since 2018.
This trader's CIK number is 1574218.
At the time of last reporting, Dietz Thomas John was the Officer of Eiger Biopharmaceuticals, Inc.. (stock ticker symbol EIGR).
Also see all insider trading activities at Eiger Biopharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | EIGR | 50,000 | $71,600 | 0 | $0 | 0 | $0 |
| 2022 | EIGR | 0 | $0 | 22,500 | $26,302 | 0 | $0 |
| 2021 | EIGR | 2,500 | $21,225 | 0 | $0 | 0 | $0 |
| 2020 | EIGR | 5,000 | $60,710 | 0 | $0 | 0 | $0 |
| 2019 | EIGR | 10,000 | $110,745 | 0 | $0 | 0 | $0 |
| 2018 | EIGR | 10,000 | $106,200 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | PRTK | 0 | $0 | 3,000 | $21,420 | 0 | $0 |
| 2018 | PRTK | 0 | $0 | 11,430 | $76,605 | 0 | $0 |
1. Eiger Biopharmaceuticals, Inc. (EIGR)
2. Paratek Pharmaceuticals, Inc. (PRTK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-23 | EIGR | Buy | 50,000 | 1.43 | 71,600 |
| 2022-12-22 | EIGR | Sale | 22,500 | 1.17 | 26,302 |
| 2021-04-09 | EIGR | Buy | 2,500 | 8.49 | 21,225 |
| 2020-03-16 | EIGR | Buy | 1,000 | 4.95 | 4,950 |
| 2020-01-10 | EIGR | Buy | 4,000 | 13.94 | 55,760 |
| 2019-04-23 | EIGR | Buy | 5,000 | 11.10 | 55,495 |
| 2019-04-22 | EIGR | Buy | 5,000 | 11.05 | 55,250 |
| 2018-12-20 | EIGR | Buy | 5,000 | 9.98 | 49,900 |
| 2018-12-06 | EIGR | Buy | 5,000 | 11.26 | 56,300 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-02-15 | PRTK | Sale | 3,000 | 7.14 | 21,420 |
| 2018-12-21 | PRTK | Sale | 9,330 | 5.01 | 46,743 |
| 2018-02-05 | PRTK | Sale | 2,100 | 14.22 | 29,862 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dietz Thomas John (Officer of Eiger Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.